MagnetisMM-7: an open label, randomized, phase 3 study of elranatamab versus lenalidomide in patients with newly diagnosed multiple myeloma who are minimal residual disease-positive after transplant

  • Mateos, Maria-Victoria; 
  • Lee, Jae Hoon; 
  • Manier, Salomon; 
  • Vandendries, Erik; 
  • Benner, Rebecca; 
  • 외 1명
Citations

WEB OF SCIENCE

3
제목
MagnetisMM-7: an open label, randomized, phase 3 study of elranatamab versus lenalidomide in patients with newly diagnosed multiple myeloma who are minimal residual disease-positive after transplant
저자
Mateos, Maria-Victoria; Lee, Jae Hoon; Manier, Salomon; Vandendries, Erik; Benner, Rebecca; Yver, Anne
발행일
2022-08
유형
Meeting Abstract
저널명
Clinical Lymphoma, Myeloma and Leukemia
권
22
페이지
S45 ~ S45